Table 2.
Subjects’ characteristics before and after the n-3 PUFA supplementation (n = 208; Men = 96 (46%) and Women = 112 (54%))
| Pre 1 | Post 1 | p 2 | |
|---|---|---|---|
| Age (years) |
30.8 ± 8.7 |
|
|
| Weight (kg)4 |
81.0 ± 13.7 |
81.2 ± 14.0 |
0.8 |
| BMI (kg/m2)3,4 |
27.6 ± 3.4 |
27.7 ± 3.6 |
0.8 |
| Waist circumference (cm)4 |
93.0 ± 10.0 |
93.0 ± 10.1 |
0.9 |
| Total cholesterol (mmol/L)5 |
4.72 ± 0.88 |
4.69 ± 0.91 |
0.6 |
| HDL (mmol/L)5 |
1.43 ± 0.35 |
1.46 ± 0.39 |
0.3 |
| LDL (mmol/L)5 |
2.75 ± 0.82 |
2.77 ± 0.85 |
0.9 |
| Triglycerides (mmol/L)3,5 |
1.19 ± 0.62 |
1.01 ± 0.51 |
0.0001* |
| Apolipoprotein B (g/L)5 |
0.83 ± 0.24 |
0.86 ± 0.23 |
0.2 |
| LDL size (Å)5 | 254.06 ± 2.65 | 254.21 ± 2.79 | 0.6 |
*p < 0.05 1Values are means ± SD, 2ANOVA for the differences before and after the supplementation, 3Values are log(10) transformed, 4Results adjusted for age and sex, 5Results adjusted for age, sex and BMI.